Search results for "FIBRILLATION"

showing 10 items of 509 documents

Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA)

2020

Sleep disordered breathing (SDB) is highly prevalent with a male to female predominance of two to one, and is more common in middle-aged and elderly subjects [1]. Affected patients often present with comorbidities such as obesity, cardiovascular disease (systemic hypertension, heart failure, atrial fibrillation), and diabetes mellitus Type II [2]. The strong overlap between the profile for SDB patients and the identified risk factors for adverse outcomes of COVID-19 infection that include age, male gender, and cardio-metabolic comorbidity [3] suggest that SDB patients may benefit from effective therapy if confronted with COVID-19 infection [4].

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyDatabases FactualPolysomnographymedicine.medical_treatmentPneumonia ViralPersonnel Staffing and SchedulingPolysomnographyDiseaseCovidsleep laboratoryBetacoronavirus03 medical and health sciencesSleep Apnea SyndromeSleep Apnea Syndromes0302 clinical medicineSurveys and Questionnairesmental disordersResearch LettermedicineHumanscardiovascular diseases030212 general & internal medicineContinuous positive airway pressurePandemicsSleep Medicine SpecialtyContinuous Positive Airway Pressuremedicine.diagnostic_testCoronavirus InfectionSARS-CoV-2business.industrySleep apneaCOVID-19Atrial fibrillationmedicine.diseaseComorbidityObesityTelemedicineEuropeSleep Medicine Specialty030228 respiratory systemHeart failureCoronavirus InfectionsbusinessDelivery of Health CaremanagementEuropean Respiratory Journal
researchProduct

The Neochord Procedure After Failed Surgical Mitral Valve Repair.

2021

Surgical mitral valve reintervention is associated with significant morbidity and mortality, and repeat repair is not always feasible. We examine the clinical outcomes of the NeoChord procedure after failed conventional mitral valve repair. A total of 312 patients were treated with the NeoChord repair procedure between January 2014 and December 2018 at 5 European centers. Clinical and echocardiographic data were reviewed to identify patients who had a prior surgical mitral valve repair procedure. The primary endpoint (Patient Success) was a composite of placement of at least 2 neochordae and end-procedure mitral valve regurgitation (MR) ≤ mild, freedom from death, stroke, structural or func…

Pulmonary and Respiratory MedicineReoperationmedicine.medical_specialtymedicine.medical_treatmentMR recurrence030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicinelawMitral valvemedicineHumansBeating-heart surgery; MR recurrence; MV repair failure; Neochords; Off-pump mitral valve surgeryAortic dissectionHeart Valve Prosthesis ImplantationMV repair failureMitral valve repairMitral regurgitationEjection fractionBeating-heart surgerybusiness.industryOff-pump mitral valve surgeryMitral Valve InsufficiencyAtrial fibrillationGeneral Medicinemedicine.diseaseIntensive care unitSurgerymedicine.anatomical_structureTreatment OutcomeNeochords030228 respiratory systemEchocardiographyMitral ValveSurgeryCardiology and Cardiovascular MedicineMitral valve regurgitationbusinessSeminars in thoracic and cardiovascular surgery
researchProduct

The mutual relationship between heart failure and atrial fibrillation

2020

Atrial fibrillation (AF) and heart failure (HF) are evolving epidemies, together responsible for substantial human suffering and health-care expenditure. The simultaneous co-hexistence of the two conditions is associated with mortality rates higher than those observed in individuals with only one or none of them. Patients with concomitant HF and AF suffer from even worse symptoms and poorer prognosis, yet evidence-based evaluation and management of this group of patients is lacking. In this review, we evaluate the common mechanisms for the development of AF in HF patients and vice versa, focusing on the evidence for potential treatment strategies. Recent data have suggested that these patie…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyAdverse outcomesbusiness.industryMortality ratelcsh:Rheart failurelcsh:MedicineAtrial fibrillationArrhythmia-induced cardiomyopathymedicine.diseaseAtrial fibrillationHeart failure.Risk FactorsHeart failureConcomitantmedicineHumansTreatment strategyBest evidenceCardiology and Cardiovascular MedicineIntensive care medicinebusinessHealthcare system
researchProduct

Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation

2017

Atrioventricular node ablation (AVNA) is generally reserved for patients whose atrial fibrillation (AF) is refractory all other therapeutic options, since the recipients will often become pacemaker dependent. In such patients, this approach may prove particularly useful, especially if a tachycardia-induced cardiomyopathy is suspected. Historically, an "ablate and pace" approach has involved AVNA and right ventricular pacing, with or without an atrial lead. There is also an evolving role for atrioventricular node ablation in patients with AF who require cardiac resynchronisation therapy for treatment of systolic heart failure. A mortality benefit over pharmacotherapy has been demonstrated in…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyCardiomyopathy030204 cardiovascular system & hematologyCardiac Resynchronization Therapy03 medical and health sciences0302 clinical medicinePharmacotherapyRefractoryHeart RateAtrioventricular node ablationInternal medicineAtrial FibrillationmedicineHumanscardiovascular diseases030212 general & internal medicinebusiness.industryCardiac Pacing ArtificialAtrial fibrillationmedicine.diseaseAtrial LeadHeart failureAtrioventricular NodeCatheter Ablationcardiovascular systemCardiologyObservational studyCardiology and Cardiovascular MedicinebusinessHeart, Lung and Circulation
researchProduct

Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities

2007

Considerable evidence is available in support of an independent association between obstructive sleep apnoea syndrome (OSAS) and cardiovascular disease, which is particularly strong for systemic arterial hypertension and growing for ischaemic heart disease, stroke, heart failure, atrial fibrillation and cardiac sudden death. The pathogenesis of cardiovascular disease in OSAS is not completely understood but likely to be multifactorial, involving a diverse range of mechanisms including sympathetic nervous system overactivity, selective activation of inflammatory molecular pathways, endothelial dysfunction, abnormal coagulation and metabolic dysregulation, the latter particularly involving in…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioCardiovascular disease intermittent hypoxia mechanisms obstructive sleep apnoeaMetabolic DiseasesRisk FactorsDiabetes mellitusInternal medicinemedicineHumansmedia_common.cataloged_instanceEuropean unionIntensive care medicineStrokemedia_commonSleep Apnea ObstructiveMechanism (biology)business.industryResearchSleep apneaAtrial fibrillationmedicine.diseaseEndocrinologyCardiovascular DiseasesHeart failurebusinessEuropean Respiratory Journal
researchProduct

Isolated Pulmonary Embolism Is Associated With a High Risk of Arterial Thrombotic Disease

2020

Background Isolated PE is associated with a higher burden of atherosclerotic disease than other manifestations of VTE. Research Question We hypothesized that the presence of isolated PE may signal a chronically elevated risk of arterial thrombotic disease. Study Design and Methods Data from the VTEval Study, a prospective cohort study enrolling individuals with clinical suspicion and imaging-based diagnosis or exclusion of VTE, were analyzed. Patients with PE received whole-leg ultrasonography to assess presence of DVT. Regularized logistic regression identified features that discriminate between isolated PE and other VTE phenotypes at clinical presentation. Survival analyses were performed…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryHazard ratioAtrial fibrillationCritical Care and Intensive Care Medicinemedicine.diseaseRate ratioThrombosisPulmonary embolismCoronary artery diseaseInternal medicinemedicineCardiologycardiovascular diseasesMyocardial infarctionCardiology and Cardiovascular MedicineProspective cohort studybusinessChest
researchProduct

Association between Tpeak-Tend/QT and major adverse cardiovascular events in patients with Takotsubo syndrome

2020

Background:Conflicting results have been described in the scientific literature regarding the relationship between electrocardiographic parameters and complications in patients with Takotsubo syndrome (TTS). Aim of the present study was to investigate whether there is an association between markers of ventricular repolarization and major adverse cardiovascular events (MACE) during hospitalisation. Methods:A retrospective chart review was conducted on a sample of patients with diagnosis of TTS, based on the fulfilment of the revised Mayo Clinic criteria. MACE included acute heart failure, cardiogenic shock, sustained ventricular tachycardia, ventricular fibrillation, and death. The following…

QT intervalmedicine.medical_specialtyelectrocardiogram030204 cardiovascular system & hematologyQT intervalTpeak–Tend intervalElectrocardiography03 medical and health sciences0302 clinical medicineTakotsubo CardiomyopathyInternal medicineHumansMedicineRepolarizationIn patientcardiovascular diseases030212 general & internal medicineAssociation (psychology)TakotsuboRetrospective StudiesrepolarizationTakotsubo syndromebusiness.industrymajor cardiovascular eventsArrhythmias CardiacGeneral MedicineVentricular FibrillationCardiologyTpeak tendCardiology and Cardiovascular MedicinebusinessActa Cardiologica
researchProduct

RIGHT LOBAR PULMONITIS A POSSIBLE CAUSE OF LONE ATRIAL FIBRILLATION

2007

RIGHT LOBAR PULMONITIS A POSSIBLE CAUSE OF LONE ATRIAL FIBRILLATION

RIGHT LOBAR PULMONITIS A POSSIBLE CAUSE OF LONE ATRIAL FIBRILLATION
researchProduct

Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort…

2015

Objective: To investigate the relationship between Ankle-Brachial Index (ABI) and renal function progression in patients with atrial fibrillation (AF). Design: Observational prospective multicentre cohort study. Setting: Atherothrombosis Center of I Clinica Medica of 'Sapienza' University of Rome; Department of Medical and Surgical Sciences of University Magna Græcia of Catanzaro; Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study. Participants: 897 AF patients on treatment with vitamin K antagonists. Main outcome measures: The relationship between basal ABI and renal function progression, assessed by the estimated Glomerular Filtration R…

RegistrieMaleAnkle brachial index atrial fibrillation renal functionCross-sectional studyAngiotensin-Converting Enzyme InhibitorsBlood PressureCardiovascular Medicineurologic and male genital diseasesKidneyRisk FactorsAtrial FibrillationOdds RatioSurveys and Questionnaireatrial fibrillation1506Prospective StudiesRenal InsufficiencyPractice Patterns Physicians'Prospective cohort studyMedicine (all)Atrial fibrillationGeneral MedicineMiddle Agedmedicine.anatomical_structureItalyHypertensioncardiovascular systemCardiologyDisease ProgressionFemaleVitamin K antagonistABICohort studyHumanGlomerular Filtration RateAnkle brachial index; atrial fibrillation; renal function1683medicine.medical_specialtyLogistic ModelNon-Vitamin K oral anticoagulantRenal functionrenal function declineAnkle-Brachial IndexNOInternal medicineAged; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Cross-Sectional Studies; Disease Progression; Female; Humans; Hypertension; Italy; Kidney; Logistic Models; Male; Middle Aged; Odds Ratio; Prospective Studies; Renal Insufficiency; Risk Factors; Ankle Brachial Index; Blood Pressure; Glomerular Filtration Rate; Medicine (all)medicineInternal MedicineHumansAnkle Brachial Indexcardiovascular diseasesIntensive care medicineAgedCross-Sectional StudieAntithrombotic therapybusiness.industryRisk FactorResearchrenal functionAnticoagulantAngiotensin-Converting Enzyme InhibitorOdds ratiomedicine.diseasebody regionsProspective StudieBlood pressureAtrial fibrillation; Ankle-Brachial Index; renal function declineCross-Sectional StudiesLogistic ModelsAnklebusinessABI renal function atrial fibrillation
researchProduct

Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation

2015

Left ventricular hypertrophy (LVH) is significantly related to adverse clinical outcomes in patients at high risk of cardiovascular events. In patients with atrial fibrillation (AF), data on LVH, that is, prevalence and determinants, are inconsistent mainly because of different definitions and heterogeneity of study populations. We determined echocardiographic-based LVH prevalence and clinical factors independently associated with its development in a prospective cohort of patients with non-valvular (NV) AF. From the "Atrial Fibrillation Registry for Ankle-brachial Index Prevalence Assessment: Collaborative Italian Study" (ARAPACIS) population, 1,184 patients with NVAF (mean age 72 ± 11 yea…

RegistrieMaleCross-sectional studyMyocardial InfarctionLongitudinal StudieLeft ventricular hypertrophyCohort Studiesnon-valvular atrial fibrillationAtrial Fibrillation80 and overPrevalenceechocardiographyMyocardial infarctionLongitudinal StudiesProspective StudiesRegistriesProspective cohort studyUltrasonographyAged 80 and overeducation.field_of_studyMedicine (all)Atrial fibrillationDiabetes MellituMiddle AgedLeft Ventricularleft ventricular hypertrophyItalyHypertensionCardiologyAge Distribution; Aged; Aged 80 and over; Ankle Brachial Index; Atrial Fibrillation; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus; Female; Humans; Hypertension; Hypertrophy Left Ventricular; Italy; Logistic Models; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Prevalence; Prospective Studies; Ultrasonography; Registries; Cardiology and Cardiovascular Medicine; Medicine (all)Hypertrophy Left VentricularFemaleCardiology and Cardiovascular MedicineHumanmedicine.medical_specialtyLogistic ModelPopulationConcentric hypertrophySocio-culturalenon-valvular atrial fibrillation left ventricular hypertrophy echocardiography cardiovascular diseasesPeripheral Arterial DiseaseAge DistributionInternal medicinemedicineDiabetes MellitusHumansAnkle Brachial Indexcardiovascular diseaseseducationAgedCross-Sectional Studiebusiness.industryAge Distribution; Aged; Aged 80 and over; Ankle Brachial Index; Atrial Fibrillation; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus; Female; Humans; Hypertension; Hypertrophy Left Ventricular; Italy; Logistic Models; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Prevalence; Prospective Studies; Ultrasonography; Registries; Cardiology and Cardiovascular MedicineOdds ratioHypertrophymedicine.diseasecardiovascular diseasesProspective StudieCross-Sectional StudiesLogistic ModelsCohort StudiebusinessAge Distribution; Aged; Aged 80 and over; Ankle Brachial Index; Atrial Fibrillation; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus; Female; Humans; Hypertension; Hypertrophy Left Ventricular; Italy; Logistic Models; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Prevalence; Prospective Studies; Ultrasonography; Registries
researchProduct